Arkolith/Insider Trading/BLPH/Form 4

Fernandes Peter

CHIEF EXECUTIVE OFFICERBellerophon Therapeutics, Inc. (BLPH) · full profile →Form 4 · filed Feb 14, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 10, 2023Grant(A)100K$1.52$152K100K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-002459) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML